comparemela.com

Latest Breaking News On - தேசிய நிறுவனம் க்கு மருத்துவ சிறப்பானது - Page 1 : comparemela.com

New research into treatment and diagnosis of long COVID

New research into treatment and diagnosis of long COVID 15 new studies across the UK will expand research into long COVID to support thousands of vulnerable people, backed by nearly £20 million through the NIHR From: 15 new studies across UK to expand research that will support thousands of vulnerable people Nearly £20 million for research projects will help improve understanding of long COVID and identify effective treatments Projects include the largest long COVID trial to date which will involve over 4,500 people Thousands of people suffering with long COVID will benefit from new research programmes backed by £19.6 million to help better understand the condition, improve diagnosis and find new treatments.

Ananda Developments Plc - Grant of Home Office Licence

Ananda Developments Plc - Grant of Home Office Licence
finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.

Khiron Comments on the Results of Project Twenty21 - UK's Largest Observational Study into Medical Cannabis Products

(1) Khiron is a founding member of Project Twenty 21 and was the first supplier of EU-GMP high-THC dried cannabis flower to the study The findings show that medical Cannabis dramatically improves quality of life for people with life-limiting conditions, including Chronic Pain, Multiple Sclerosis, Tourette s Syndrome and PTSD Legal prescriptions allow patients to access medical cannabis without engaging in criminality and to avoid dependency associated with other medicines commonly prescribed for these debilitating conditions TORONTO, May 11, 2021 /PRNewswire/ Khiron Life Sciences Corp. ( Khiron or the Company ) (TSXV: KHRN) (OTCQX: KHRNF)(Frankfurt: A2JMZC), a vertically integrated cannabis leader with core operations in Latin America and Europe, applauds the publication today in the accredited scientific journal Psychopharmacology of the first findings arising from Project Twenty 21, UK s first and largest national medical cannabis registry that was launched on November

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.